Atlas Arteria Limited (ASX:ALX – Get Free Report) announced a final dividend on Friday, March 21st, MarketIndexAU Dividends reports. Stockholders of record on Thursday, April 3rd will be paid a dividend of 0.20 per share on Thursday, April 3rd. This represents a dividend yield of 3.99%. The ex-dividend date of this dividend is Monday, March 24th.
Atlas Arteria Price Performance
The company has a market capitalization of $7.33 billion, a P/E ratio of 31.31, a P/E/G ratio of 0.31 and a beta of 0.78. The company has a current ratio of 2.26, a quick ratio of 1.77 and a debt-to-equity ratio of 27.23.
Insider Buying and Selling at Atlas Arteria
In other news, insider David Bartholomew purchased 7,700 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was purchased at an average cost of A$5.08 ($3.19) per share, with a total value of A$39,116.00 ($24,601.26). Also, insider John Wigglesworth purchased 8,000 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The shares were bought at an average cost of A$5.04 ($3.17) per share, for a total transaction of A$40,320.00 ($25,358.49). Insiders have purchased a total of 17,450 shares of company stock worth $88,099 over the last 90 days. Insiders own 27.61% of the company’s stock.
Atlas Arteria Company Profile
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States.
Further Reading
- Five stocks we like better than Atlas Arteria
- Growth Stocks: What They Are, What They Are Not
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Roth IRA Calculator: Calculate Your Potential Returns
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
- Investing in Commodities: What Are They? How to Invest in Them
- MarketBeat Week in Review – 03/17 – 03/21
Receive News & Ratings for Atlas Arteria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlas Arteria and related companies with MarketBeat.com's FREE daily email newsletter.